1. Home
  2. APAM vs HCM Comparison

APAM vs HCM Comparison

Compare APAM & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artisan Partners Asset Management Inc.

APAM

Artisan Partners Asset Management Inc.

N/A

Current Price

$38.57

Market Cap

2.4B

Sector

Finance

ML Signal

N/A

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$13.04

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APAM
HCM
Founded
1994
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
APAM
HCM
Price
$38.57
$13.04
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
★ $34.50
$21.14
AVG Volume (30 Days)
★ 1.4M
36.3K
Earning Date
10-27-2026
07-30-2026
Dividend Yield
★ 10.49%
N/A
EPS Growth
★ 10.66
N/A
EPS
★ 2.96
N/A
Revenue
★ $1,196,688,000.00
N/A
Revenue This Year
$4.14
$14.19
Revenue Next Year
N/A
$11.67
P/E Ratio
$12.91
★ $5.49
Revenue Growth
★ 7.63
N/A
52 Week Low
$30.86
$9.77
52 Week High
$46.53
$16.33

Technical Indicators

Market Signals
Indicator
APAM
HCM
Relative Strength Index (RSI) 66.74 41.56
Support Level $35.02 $13.00
Resistance Level $40.50 $15.10
Average True Range (ATR) 1.05 0.33
MACD 0.83 -0.14
Stochastic Oscillator 97.92 4.95

Price Performance

Historical Comparison
APAM
HCM

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: